Omega-3 fatty acid supplementation for expectant mothers with depressive symptoms in Japan and Taiwan: An open-label trial

Psychiatry Clin Neurosci. 2016 Jun;70(6):253-4. doi: 10.1111/pcn.12388. Epub 2016 May 6.

Daisuke Nishi^{1

2}, Kuan-Pin Su³, Kentaro Usuda^{1

2}, Yi-Ju Jill Chiang³, Tai-Wei Guu³, Kei Hamazaki⁴, Naoki Nakaya⁵, Toshimasa Sone⁶, Yo Sano⁷, Hiroe Ito¹, Keiichi Isaka¹, Kenji Hashimoto⁸, Tomohito Hamazaki⁹, Yutaka J Matsuoka^{1

10}

¹ Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan.
² Department of Mental Health Policy and Evaluation, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
³ Department of Psychiatry & Mind-Body Interface Laboratory, China Medical University, Taichung, Taiwan.
⁴ Department of Public Health, Faculty of Medicine, University of Toyama, Toyama, Japan.
⁵ Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
⁶ Department of Rehabilitation, Faculty of Health Science, Tohoku Fukushi University, Sendai, Japan.
⁷ Department of Obstetrics and Gynecology, Toda Chuo Women's Hospital, Toda, Japan.
⁸ Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
⁹ Department of Medicine, Toyama Jonan Onsen Daini Hospital, Toyama, Japan.
¹⁰ Division of Health Care Research, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

No abstract available

Publication types